Keyword: Quotient Clinical
Quotient Clinical has rebranded as Quotient Sciences, and right after that, made its third purchase this year.
Lilly's longtime CFO Rice will retire, Akari's CEO resigned amid a false data scandal, MannKind replaced its CEO with the hope to revive Afrezza.
Just a few days after the announcement of the acquisition of SeaView, U.K.’s Quotient Clinical further strengthened its foothold in the U.S. by bringing in QS Pharma.
Quotient Clinical, a U.K.-based CRO focused on early-stage drug development services, has taken SeaView Research under its operations, thus expanding into the U.S. market.